Get started Log in

LUNG — Pulmonx Share News

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Market Cap
$52.80m
Enterprise Value
$28.54m
Revenue
$90.50m

Brief: Pulmonx Announces Anthem Blue Cross Blue Shield Now Provides Coverage For Severe COPD/Emphysema Treatment
20/08/2021 21:33
Pulmonx Corp reports results for the quarter ended in June - Earnings Summary
03/08/2021 23:10
Brief: Pulmonx Reports Q2 2021 Financial Results
03/08/2021 21:10
Brief: Pulmonx Welcomes Two New Board Members
02/08/2021 13:51
Pulmonx Corp expected to post a loss of 37 cents a share - Earnings Preview
31/07/2021 01:52
Brief: Pulmonx Announces Long-Term Follow-Up Data Confirming Significant Benefits Of Zephyr Valve For Patients With Severe Copd/Emphysema
27/07/2021 15:33
Pulmonx Corp reports results for the quarter ended in March - Earnings Summary
04/05/2021 23:34
Brief: Pulmonx Q1 Revenue Rose 7% To $9.2 Million
04/05/2021 22:12
Brief: Pulmonx Posts Q4 Loss Per Share Of $0.27
02/03/2021 21:20
Brief: Pulmonx Reports Third Quarter 2020 Financial Results
10/11/2020 21:05
Pulmonx: More than doubles in Nasdaq debut
01/10/2020 16:42
Brief: Pulmonx announces Pricing Of Its Upsized Initial Public Offering Of 10,000,000 Shares Of Its Common Stock At $19.00 Per Share
01/10/2020 09:40
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:02 AM
01/10/2020 09:02